Navigation Links
SGX Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
Date:3/20/2008

SAN DIEGO, March 20 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) will be presenting at the Future Leaders in the Biotech Industry Conference hosted by BioCentury and Thomson on Thursday, March 27, 2008 at 9:00 AM Eastern Daylight Time. Mike Grey, president and chief executive officer of SGX Pharmaceuticals, will provide an overview of the Company's oncology pipeline. The conference is being held at the Millennium Broadway Hotel and Conference Center in New York City.

A live webcast of the presentation will be available under the investor relations section of the Company's website at http://www.sgxpharma.com. Replays of the presentation will be available for 90 days following the event. Please connect to the Company's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About SGX Pharmaceuticals

SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The SGX oncology pipeline includes drug candidates from its FAST(TM) drug discovery platform, such as SGX523, a MET kinase inhibitor currently in Phase 1 clinical studies, next generation BCR-ABL inhibitors being developed by SGX and in partnership with Novartis and a portfolio of inhibitors of various oncology targets. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
2. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
3. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
4. Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results
5. MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
6. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
7. NPS Pharmaceuticals Reports 2007 Financial Results
8. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
9. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
10. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
11. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ... of Dr. Alan Warrander to the role of ... ,, "Dr. Warrander will be responsible for the ... said Dr. Brad Thompson, President and CEO of ... of a Phase 3 trial examining REOLYSIN in ...
(Date:12/10/2009)... Institute (NEI), a division of the National Institutes of Health ... help fund its development of a non-invasive, passive diffusion-based treatment ... ... Salt Lake City, UT (PRWEB) December 10, 2009 ... National Institutes of Health (NIH), awarded a $2.18 million grant ...
(Date:12/10/2009)... China Biologic,Products, Inc. (Nasdaq: CBPO ) ("China ... biopharmaceutical companies in China, today announced,that the Company,s ... at the,NASDAQ MarketSite in New York City at ... China Biologic,s common stock ... 2, 2009, under the ticker symbol "CBPO." , ...
(Date:12/10/2009)... DNDN ) today announced that Hans Bishop has ... 4, 2010. Mr. Bishop most recently served as ... he was responsible for a diverse portfolio of oncology, ... as an executive vice president of Bayer HealthCare LLC. ... management team, Mr. Bishop will be responsible for preparing ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Dendreon Appoints Hans Bishop as Chief Operating Officer 2
... The Eniva Research Group has,released results ... Pauling,Micronutrient Research Institute at Oregon State University ... DNA protective,anti-mutagenic activity for human cells. This ... an ongoing investigative effort to further identify,mechanisms ...
... On June 27, 2008,GeneraMedix Inc. received approval ... its Epoprostenol for Injection 1.5 mg New Drug,Application ... indicated for the long-term,intravenous treatment of primary pulmonary ... of disease in NYHA,Class III and Class IV ...
... July 3 Advanced Life Sciences,Holdings, Inc. ... engaged in the,discovery, development and commercialization of ... cancer and respiratory diseases, today,announced that it ... after the,Russell Investment Group reconstituted its comprehensive ...
Other Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2GeneraMedix Inc. Receives Approval for Epoprostenol for Injection 1.5 mg 2Advanced Life Sciences Added to Russell Microcap Index 2Advanced Life Sciences Added to Russell Microcap Index 3
(Date:12/11/2009)... ROUGE, LAKeeping with the global "green" trend, ... education lessons to enhance students, science knowledge. ... into the curriculum raises not just science ... scores in other subject areas. Naturally, educators ... integrate these relevant lessons into the classroom ...
(Date:12/11/2009)... under stress collectively weigh and initiate different survival strategies ... make strategic decisions that affect their health, wealth and ... published this week in the early online edition of ... Sciences , was accomplished when the scientists applied the ... interplay of genes and proteins that colonies of bacteria ...
(Date:12/11/2009)... This release is available in French . ... have discovered a novel molecular mechanism that prevents cancer. ... Molecular Cell , scientists from the Universit de ... found that the SOCS1 molecule prevents the cancer-causing activity ... inflammation diseases such as Crohns, in smokers and people ...
Breaking Biology News(10 mins):Students learn environmental stewardship, improve science scores 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Scientists identify natural anti-cancer defenses 2Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 1Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 2Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 3Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 4Cell Therapeutics Inc 28CTI 29 Piper Jaffray Presentation to be Webcast 62317 1Childhood lead exposure causes permanent brain damage 62312 1Childhood lead exposure causes permanent brain damage 62312 2
... 2008] Three-quarters of youths with type 1 diabetes were ... a study by researchers at the Joslin Diabetes Center ... D supplementation to prevent bone fragility later in life. , ... D inadequacy," said Lori Laffel, M.D., M.P.H., Chief of the ...
... A newly published genome sequence of a breast ... blueprint involving breaks and fusions of genes and a ... of Medicine in a report that appears online in ... a computer program that has become buggy and transcends ...
... new family of fluorescent probes called hydrocyanines that can ... reactive oxygen species. Reactive oxygen species are highly reactive ... variety of inflammatory diseases, including cancer and atherosclerosis. , ... to detect the reactive oxygen species, superoxide and ...
Other Biology News:Joslin research finds nearly three-quarters of youths with diabetes insufficient in vitamin D 2Breast cancer genome shows evolution, instability of cancer 2Breast cancer genome shows evolution, instability of cancer 3Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo 2Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo 3
... The Jouan RCT series of refrigerated ... suited to trapping of low volatility/aqueous solvents ... with RC10 and other vacuum concentrators/centrifugal evaporators. ... in cooling systems such as used in ...
96 Well Plate Sterile, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
...
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
Biology Products: